Hirschsprung disease (HSCR) is a complex developmental disorder characterised by the lack of enteric neurons in distal portions of the gut. Importantly, HSCR presents a dramatic sex bias with at least 4 times more males affected than females for reasons that are unknown. Genome-wide mapping studies of patients have failed to identify sex-linked genes associated with HSCR while experimental studies have largely overlooked the effects of sex.
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Here, we exploit several mouse models of HSCR, including Sox10LacZ/+, Ret 51/51 and Ret S697a/S697a, to investigate the sex bias. We identify a difference in phenotype severity at early postnatal stages in all the models, with males exhibiting greater extents of hypoganglionosis or aberrant ENS in the colon compared to females. At embryonic stage E14.5, Sox10LacZ/+ and Ret 51/51 guts showed no obvious differences in phenotype severity. This defines the critical period during which the sex bias may operate.
To identify sex-specific differences in gene expression we performed RNAseq analyses on populations of normal neural crest cell derivatives and mesenchymal cells isolated from Wnt1-cre;R26YFP E15.5 embryonic guts. Preliminary analyses suggest that males have higher levels of apoptosis in enteric neural crest cells, while females have increased levels of proliferation. Further transcriptomic analyses performed at additional embryonic stages as well as in our HSCR models will allow us to identify candidate genes and specific pathways that are upregulated or downregulated in males and females, causing males to be more affected.
To investigate whether these sex differences are due to sex-linked genes or sex hormones, we will also exploit the "four-core genotype model" to study our mutations of interest in XX and XY males and XX and XY females. In combination with our transcriptomic analyses, this provides groundwork to understand the sex-linked disease mechanisms leading to the sex bias of HSCR. The purpose of the current study is to understand the connection between FSH and Notch signaling in ovarian cancer progression.
There was a dose dependent increase in Notch signaling activity in response to FSH in the ovarian cancer cell line Ovcar-3. In these cells, there was a marginal increase in Notch signaling activity within 3 hrs of FSH (100mIU/ml) treatment, which increased to 4 fold after 36 hrs and remained constant thereafter. There was also an increase in Notch 3 receptor and the ligands Delta 1 (DLL1) and Delta 4 (DLL4), both at the transcripts and protein levels in response to FSH with concomitant increase in the Notch downstream gene HeyL transcript. Addition of exogenous DLL4 showed an additive effect of FSH on the Notch signaling activity in Ovcar-3 cells. These effects were abrogated in the presence of the antibody raised against the extracellular domain of FSH receptor. An ScFv specific for Notch3 NRR also inhibited FSH induced notch signaling in the Ovcar-3 cells. FSH also increased the proliferation of ovarian cancer cells, which was inhibited by FSHr and Notch antagonist. Ovcar-3 spheroids also showed an upregulated notch signaling in response to FSH. Also, FSH increased the aggregation of Ovcar3 cells in non adherent conditions to make bigger spheroids. Larger spheroids are known to have chemoresistance and known to play a role in metastasis. Further analysis showed an increase in the expression of STAT-3, a downstream target of FSH signaling, which is also a common transcript factor for Notch3, DLL1 and DLL4. Thus the current study shows the crosstalk between FSH and Notch signaling in the ovarian cancer cells, which seems to be an loop in ovarian cancer progression. Failure of neural tube closure during embryonic development can result in anencephaly (absence of brain) which is one of the most severe and common birth defects worldwide (5-10 cases in 10,000 live births). To better understand its aetiology and pathogenesis we selected families with recurrent anencephalic foetuses.
By whole-exome sequencing, we identified a recessive germline 21 bp in-frame deletion in the NUAK2 gene that segregated with the absence of brain in three foetuses born to consanguineous parents. NUAK2 (a.k.a SNARK) encodes a serine/threonine kinase, a member of the AMPK-related kinase family. In vitro phosphorylation assays demonstrated that the 7 amino-acid deletion in the NUAK2 kinase domain abrogated its kinase activity. Consistent with this being a null allele, a knockout of NUAK2 in mice also caused severe exencephaly (Ohmura et al., 2012) .
To further study the role of NUAK2 during neural tube morphogenesis, cerebral organoids were generated from patientderived induced pluripotent stem cells. Abnormal neural tube-like structures were observed in mutant mini-brains compared to control, indicating that NUAK2 is key to impart proper neuroepithelial architecture. SILAC pull-down and immunostainings in mini-brain suggest that NUAK2 regulates the actomyosin and tubulin networks via phosphorylation of multiple targets, forcing apical constriction of neuroepithelial cells which drives dynamic closure of the neural tube.
Our results establish NUAK2 as an indispensable kinase for brain development and may also provide valuable insights into the processes that govern cell shape and migration in NUAK2-associated cancers. Adolescent idiopathic scoliosis (IS), a disease characterized by 3D spinal curvatures, afflicts 3% of children worldwide. However, the underlying developmental basis for this disease has remained unknown. Recently, the teleost fish have emerged as robust models of IS. Using zebrafish, we have discovered that spinal curves are caused by loss of motile cilia function, which in turn results in defective CSF flow. Human IS can be caused by mutations in PTK7, and we find that cilia/CSF flow defects are also the basis of spinal curves in ptk7 zebrafish mutants. Thus, we propose that IS can be caused by disruptions to CSF flow during the growth phase, providing a novel mechanism for this prevalent disease. We also give evidence that spinal curves can be partially rescued by restoring cilia motility after curve onset, opening potential therapeutic avenues. Overall, our study provides new insight into spine formation and the maintenance of spine linearity. Elk1 is an ETS Class I, TCF subfamily transcription factor known as a well established downstream effector of the MAPK pathway and implicated in the causation of a variety of cancers. Recent in-vitro evidence places Elk1 and the other TCFs in the context of the cardiogenic transcription factor network but the in-vivo role of the TCFs in cardiogenesis remains unexplored.
Here, we provide the first in-vivo evidence of the role of the Elk1 in cardiogenesis using a zebrafish mutant with disrupted DNA binding domain (elk1
) and cardiac defects, including valve displacement/ elongation and hypertrophic/hyperplastic changes. elk1 -543/-543 are predisposed to early embryonic death, with high incidence of heart looping defects and accelerated growth among survivors.
RNA-sequencing (RNA-seq) at 6dpf provides insights into the basis of anatomical defects, with upregulation of MAPK components and downregulation of trim63a, encoding a homeostatic protein involved in reducing muscle mass, downregulation of which is associated with Hypertrophic Cardiomyopathy (HCM) in humans.
The inverse relationship between MAPK components and Trim63a is well-described although its fundamental basis is unknown. Here we provide the first mechanistic insight into this relationship, indicating that MAPK perturbations likely converge via the TCFs at the trim63a promoter, downregulating trim63a to mediate HCM.
RNA-seq at the tail bud stage has allowed us to identify putative, genomically hard-wired compensation mechanisms whereby loss of TCF function causes downregulation of tumor suppressor genes. We hypothesize this promotes proliferation and embryonic survival via non-optimal (compensatory) pathways, and is the fundamental mechanism underlying observed phenotypic defects.
The sum of anatomical and molecular changes observed in elk1 -543/-543 mimic a group of congenital syndromes known as "RASopathies" in humans. Overall, our data provides high resolution insights into the time line of molecular events underlying RASopathies/ MAPK pathway defects and their relationship to molecules imperative in heart patterning and homeostasis. Background: Rab23 is a GTPase protein and is proposed to regulate intracellular vesicle trafficking. Mutations in Rab23 causes Carpenter Syndrome; heart defect, polysyndactyly, obesity and most prominently craniosynostosis. Craniosynostosis is a premature fusion of calvarial sutures that largely affecting brain, facial, skull growth & development. Craniosynostosis is the second largest human birth defects.
Results: We show that in Rab23 -/-mice Fgf10 is overexpressed in the lambdoid suture. Upregulation of Fgf10 enhances the expression of its receptor Fgfr1b and Fgfr2b in the mutant lambdoid sutural sites that subsequently activate MAPK signaling and enhance pErk levels. Pitx2, a homeodomain transcription factor is known as an upstream regulator of Fgf10 expression. Our study shows that Rab23 deficiency causes lambdoid suture craniosynostosis through a positive regulatory axis of Pitx2-Fgf10-MAPK signaling. Moreover, overall upregulation of Gli transcription factors and Hh giving further evidence of MAPK pathway over activation, which results in higher cell proliferation in the mutant lambdoid suture and leading to premature suture fusion due to an imbalance between osteoblast proliferation and differentiation. We further validated our hypothesis by in vitro lambdoid sutural tissue culture in presence or absence of Mapk signaling antagonist U0126. Our result suggests that inhibiting Mapk signaling by U0126 can rescue mutant lambdoid suture from premature fusion in Rab23 -/-mice. Conclusion: These findings suggest a novel role of Rab23 during lambdoid suture development through Pitx2-Fgf10-MAPK signaling.
Significance: Targeting Fgf10 or inhibiting MAPK signaling might be a potential tool to treating patients with lambdoid suture craniosynostosis. doi:10.1016/j.mod.2017.04.028
